Concepedia
Statistics
Publications
9
Citations
365
H-Index
Active since
2020
Affiliations
Vanda Pharmaceuticals (United States)(Current)
Sandra Smieszek is an author at Vanda Pharmaceuticals (United States) specializing in medicine, virology, and covid-19.
Top concepts
MedicineCovid-19VirologyImmunologyCovid-19 EpidemiologySleepPathologyAutoimmunityPathogenesisPharmacology
Publications per year
2020–2022
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
Sandra Smieszek, Bart Przychodzen, Mihael H. Polymeropoulos · International Journal of Antimicrobial Agents · 2020 · 117 citations · Full text
Molecular Virology, Pathogenesis, Immunology +6
Correlation of age-of-onset of Atopic Dermatitis with Filaggrin loss-of-function variant status
Sandra Smieszek, Sarah E Welsh, Chao Xiao et al. · Scientific Reports · 2020 · 53 citations · Full text
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
Sandra Smieszek, Vasilios M. Polymeropoulos, Changfu Xiao et al. · Journal of Global Antimicrobial Resistance · 2021 · 46 citations · Full text
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues
Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur et al. · Cell Reports · 2021 · 46 citations · Full text
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’
Sandra Smieszek, Bartlomiej Przychodzen, Vasilios M. Polymeropoulos et al. · Cytokine · 2021 · 32 citations · Full text
1–5 of 9